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Abstract
It is known that chronic high levels of corticosterone (CORT) enhance aversive responses such as avoidance and contextual 
freezing. In contrast, chronic CORT does not alter defensive behavior induced by the exposure to a predator odor. Since differ-
ent defense-related responses have been associated with specific anxiety disorders found in clinical settings, the observation 
that chronic CORT alters some defensive behaviors but not others might be relevant to the understanding of the neurobiology 
of anxiety. In the present study, we investigated the effects of chronic CORT administration (through surgical implantation of 
a 21-day release 200 mg pellet) on avoidance acquisition and escape expression by male Wistar rats (200 g in weight at the 
beginning of the experiments, N = 6-10/group) tested in the elevated T-maze (ETM). These defensive behaviors have been 
associated with generalized anxiety and panic disorder, respectively. Since the tricyclic antidepressant imipramine is success-
fully used to treat both conditions, the effects of combined treatment with chronic imipramine (15 mg, ip) and CORT were also 
investigated. Results showed that chronic CORT facilitated avoidance performance, an anxiogenic-like effect (P < 0.05), without 
changing escape responses. Imipramine significantly reversed the anxiogenic effect of CORT (P < 0.05), although the drug did 
not exhibit anxiolytic effects by itself. Confirming previous observations, imipramine inhibited escape responses, a panicolytic-like 
effect. Unlike chronic CORT, imipramine also decreased locomotor activity in an open field. These data suggest that chronic 
CORT specifically altered ETM avoidance, a fact that should be relevant to a better understanding of the physiopathology of 
generalized anxiety and panic disorder.
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It has been shown that short-term glucocorticoid secre-
tion is essential for the maintenance of several behavioral 
events, and crucial for the expression of fear/anxiety re-
sponses (1-3). In contrast, clinical observations suggest that 
chronic high levels of glucocorticoids, which are most often 
a result of prolonged stress, lead to maladaptive anxiety 
and/or depressive disorders (3). 
A number of experimental studies have also demon-
strated the anxiogenic effects of the exogenous administra-
tion of glucocorticoids. It has been observed, for instance, 
that post-training injections of corticosterone (CORT) 
enhance the animals’ performance in several aversive 
tasks, facilitating responses such as inhibitory avoidance 
and contextual freezing (2). Increases in contextual freez-
ing have also been observed when CORT is administered 
prior to conditioning (1). On the other hand, chronic CORT 
does not alter defensive behavior induced by an innate fear 
stimulus, i.e., exposure to a predator odor (4). 
Although the distinction between fear and anxiety has 
not always been clear, the ethopharmacological analysis of 
the rodent defensive repertoire developed by Robert and 
Caroline Blanchard (5) has provided a sound theoretical 
framework. According to these investigators, anxiety is an 
emotion related to behavioral inhibition and risk assessment, 
behaviors that are observed in situations of potential danger, 
either because the context is new or because the aversive 
stimulus was once present in the past. On the other hand, 
fear is associated with behavioral responses that occur in 
situations of real danger. In such cases, the animal either 
escapes/flees from the situation or exhibits immobility 
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(freezing) when there is no possibility of escape. Gray and 
McNaughton (6) have also emphasized the importance of 
approach-avoidance conflict for the distinction between 
anxiety and fear. According to the authors (6,7), behavioral 
inhibition and risk assessment are responses occurring 
when an animal is faced with a threat, which involves a 
conflict between approach and avoidance (e.g., searching 
for food in an area previously visited by a predator). Risk 
assessment functions to reduce the level of perceived 
threat, while behavioral inhibition reduces risk in cases of 
real threat. On the other hand, when there is no tendency 
to approach the feared situation, animals often exhibit re-
sponses such as escape or flight. These behaviors have 
been associated with fear (6,7). In terms of psychopathology, 
it has been proposed that the neurobiological substrates 
that regulate anxiety are disrupted in generalized anxiety, 
while dysfunction of the brain circuitry controlling fear has 
been related to panic disorder (5,7). 
In order to better understand how CORT administration 
alters defensive responses specifically related to anxiety 
disorders found in clinical settings, in the present study we 
investigated the effects of chronic CORT (200 mg pellets, 
21-day release) on avoidance acquisition and escape ex-
pression by male Wistar rats tested in the elevated T-maze 
(ETM) (8). The pharmacological exploitation of the ETM 
has shown that these two measurements are differently 
affected by drug treatments. Thus, compounds represen-
tative of three classes of anxiolytics - namely the agonist 
of benzodiazepine receptors diazepam, the serotonin 1A 
agonist buspirone, and the nonselective type 2 antagonist 
ritanserin - have been shown to selectively impair ETM 
avoidance while leaving escape unchanged (8,9). These 
results are compatible with the view that ETM avoidance 
relates to generalized anxiety disorder (8,9). In contrast, the 
escape task is insensitive to different classes of anxiolytics, 
and is impaired by chronic, but not acute administration of 
imipramine (10), clomipramine and fluoxetine (11), drugs 
that are used to treat panic disorder. As a result, ETM escape 
has been used as an animal model of panic. 
Since the tricyclic antidepressant imipramine is suc-
cessfully used to treat both generalized anxiety and panic 
disorder, the effects of combined treatment with chronic 
imipramine (15 mg, ip) and CORT were also investigated. 
In order to avoid confounding results due to drug effects 
on locomotor activity, after the tests in the ETM the animals 
were also evaluated in an open field. 
Material and Methods
Subjects
Thirty-three male Wistar rats (Universidade Federal de 
São Paulo, CEDEME, Brazil), weighing approximately 200 g 
at the beginning of the experiment (300 g on the day of the 
ETM tests), were housed in groups of 5-6 per cage. After 
surgery to implant the CORT pellets, animals were housed 
in pairs in Plexiglas-walled cages until testing. Room tem-
perature was controlled (22 ± 1°C) and a light-dark cycle was 
maintained on a 12-h on-off cycle (7:00-19:00 h lights on). 
Food and water were available throughout the experiments. 
The present study was approved by the Ethics Committee 
for Animal Research of the Universidade Federal de São 
Paulo under protocol number 2179/08 and was performed 
in compliance with the recommendations of the Brazilian 
Society of Neuroscience and Behavior (SBNeC), which 
are based on the US National Institutes of Health Guide 
for Care and Use of Laboratory Animals. 
Apparatus
The ETM was made of wood and had 3 arms of equal 
dimensions (50 x 12 cm). One of the arms was enclosed by 
40-cm high walls and was oriented perpendicularly to two 
opposed open arms. The whole apparatus was elevated 
50 cm above the floor. To avoid falls, the open arms were 
surrounded by a 1-cm high Plexiglas rim. 
The open field test was performed in a round arena (60 
x 60 cm), with the floor divided into 16 parts, and walls 50 
cm high. Luminosity at the level of the maze arms or the 
open field center was 60 lux. 
Drugs
Imipramine (15 mg/kg; Sigma, USA) was dissolved in 
sterile 0.9% saline. Control animals received sterile 0.9% 
saline alone. Drug and saline were administered ip in a 
volume of 1 mL/kg.
Surgery
Rats were anesthetized with an ip injection of 80 mg/kg 
ketamine hydrochloride and 10 mg/kg xylazine (Agribrands, 
Brazil). A 1-cm incision was made through the skin of the 
upper back of the animal and a 2-cm subcutaneous pocket 
was opened horizontally with a pair of forceps to allow the 
implant of a slow-release CORT pellet (200 mg, 21-day 
release; Innovative Research of America, USA). The pel-
let was inserted into the pocket and the incision sutured. 
The dose of CORT used here has been reported to result 
in plasma levels of 13.60 ± 0.89 µg/dL (mean ± SEM) in 
the 18th day of treatment (4). Sham rats were subjected to 
the same surgical procedure except that a pellet was not 
implanted. To prevent infection, all animals were injected 
im with a 0.2-mL pentabiotic preparation (Pentabiótico 
Veterinário Pequeno Porte; Forte Dodge, Brazil; 600,000 IU 
benzylpenicillin benzathine, 300,000 IU benzylpenicillin 
procaine, 300,000 IU benzylpenicillin potassium, 250 mg 
dihydrostreptomycin sulfate, 250 mg streptomycin sulfate, 
diluted in 3 mL sterile 0.9% saline) and with the anti-
inflammatory flunixin meglumine (1 mL/kg, sc; Banamine; 
Fort Dodge) at the end of surgery.
Procedure
CORT and sham animals were treated daily for 21 days 
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with either imipramine (15 mg/kg, ip) or saline (1 mL/kg). 
On the 20th day, the animals were exposed to one of the 
open arms of the ETM for 30 min as described by Sena et 
al. (12), immediately before treatment. It has been shown 
that pre-exposure renders the escape task more sensitive 
to the effects of antipanic drugs because it shortens the 
latencies of withdrawal from the open arm during the test 
(12). On the next day, 30 min after the injection of imipramine 
or saline, ETM avoidance was measured by recording the 
time taken for the rats to withdraw from the enclosed arm 
of the maze in three consecutive trials at 30-s intervals 
(baseline, avoidance 1 and 2). Following avoidance train-
ing (30 s), each animal was placed at the end of the same 
open arm used in the pre-exposure session and the time 
taken to leave this arm was recorded in three consecutive 
trials (escape 1 to 3), again with 30-s inter-trial intervals. 
Immediately after the tests in the ETM, animals were placed 
in the center of the open field and allowed 
to freely explore for 5 min. 
Statistical analysis
A three-factor design was used to ana-
lyze the T-maze results, with the two treat-
ments (treatment 1: sham x CORT; treatment 
2: saline x imipramine) as the independent 
factors and trials (baseline, avoidance 1 and 
2 or escape 1, 2, and 3 latencies) as the 
dependent factors. Locomotor activity data 
in the open field were analyzed by two-way 
ANOVA. In case of significant interactions 
between factors, group comparisons were 
made by the Duncan test. A value of P ≤ 0.05 
was considered to be significant.
Results
Figure 1 (upper panel) shows the ef-
fects of CORT and imipramine on ETM 
avoidance acquisition. Three-factor ANOVA 
showed a significant effect of trials [F(2,58) 
= 27.15; P < 0.001], CORT [F(1,29) = 5.10; 
P < 0.05], imipramine [F(1,29) = 11.53; P < 
0.001], and CORT by imipramine interaction 
[F(1,29) = 9.78; P < 0.001]. There was no 
trial by treatment interaction: trials by CORT 
[F(1,29) = 0.02; P > 0.05], trials by imipramine 
[F(1,29) = 0.02; P > 0.05], trials by CORT by 
imipramine [F(1,29) = 0.16; P > 0.05]. The 
Duncan post hoc test showed that animals 
treated with CORT were significantly differ-
ent from all the other groups at baseline and 
in the two avoidance measurements, and 
that treatment with imipramine significantly 
counteracted the effects induced by CORT 
administration in the three trials.
The lower panel of Figure 1 shows the effects of CORT 
and imipramine on ETM escape. Three-factor ANOVA 
showed a significant effect of CORT [F(1,29) = 6.70; P < 
0.05], imipramine [F(1,29) = 15.40; P < 0.001], CORT by 
imipramine [F(1,29) = 9.84; P < 0.01] and trials by imipramine 
[F(2,58) = 2.88; P < 0.05]. There was no significant effect 
of trials [F(2,58) = 1.09; P > 0.05], trials by CORT [F(2,58) 
= 2.88; P > 0.05], or trials by CORT by imipramine [F(2,58) 
= 0.09; P > 0.05]. The Duncan post hoc test showed that 
sham animals treated with imipramine were different from 
the control group in all escape measurements, and that 
CORT counteracted the effects of imipramine in escape 
2 and 3.
As shown in Figure 2, CORT did not alter the number 
of crossings [F(1,29) = 0.72; P > 0.05] or the number of 
rearings [F(1,29) = 0.33; P > 0.05]. Imipramine altered both 
measurements: crossings [F(1,29) = 6.14; P < 0.05] and 
Figure 1. Effects of chronic corticosterone (200 mg, 21-day release pellets) and 
imipramine (15 mg/kg) on avoidance (upper panel) and escape (lower panel) la-
tencies measured in the elevated T-maze. The latencies to leave the enclosed arm 
(baseline, avoidance 1 and avoidance 2) or one of the open arms (escape 1-3) 
were measured sequentially at 30-s intervals beginning 30 min after ip treatment 
with imipramine or saline. Data are reported as means ± SEM. N = 6-10 per treat-
ment group. SAL = saline; CORT = corticosterone; IMI = imipramine. *P < 0.05 
compared to control (SHAM/SAL) in the same trial; +P < 0.05 compared to the 
other groups in the same trial (ANOVA followed by the Duncan post hoc test).
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rearings [F(1,29) = 5.92; P < 0.05]. There 
were no significant interactions between 
treatments and crossings [F(1,29) = 0.06; P 
> 0.05] or treatments and rearings [F(1,29) 
= 1.09; P > 0.05]. 
Discussion
The results of the present study suggest 
that chronic CORT facilitates ETM avoidance 
performance, an anxiogenic-like effect, with-
out changing escape responses. Imipramine 
significantly reversed the anxiogenic effect 
of CORT, although by itself the drug did not 
alter avoidance measurements. On the other 
hand, imipramine inhibited escape responses, 
a panicolytic-like effect. This effect was also 
reversed by chronic treatment with CORT. 
Moreover, unlike chronic CORT, imipramine 
decreased both the number of crossings and rearings in 
an open field.
The anxiogenic effects observed on ETM avoidance 
corroborate previous evidence showing that treatment with 
CORT enhances acquisition and consolidation of a number 
of defense-related responses, such as inhibitory avoidance 
and contextual freezing (1,2). Like ETM avoidance, these 
responses involve behavioral inhibition and occur in re-
sponse to a potential threat. For the measurement of ETM 
avoidance, repeated exposure of the animal to the enclosed 
arm is necessary. When placed at the end of the enclosed 
arm for the first time, the rat does not see the open arms 
until it pokes its head beyond this arm walls. Being in the 
open arms seems to be an aversive experience, since rats 
have an innate fear of height and openness (13). Thus, in 
subsequent trials, the animal takes a longer time to withdraw 
from the enclosed arm towards the open space, showing 
the acquisition of ETM avoidance. 
It is interesting to point out, however, that in the present 
study CORT also significantly enhanced baseline latencies. 
Traditionally, baseline latencies are a measurement of 
motor activity and not of anxiety (10). Nevertheless, since 
CORT did not alter motor behavior in the open field, the 
significant increase in baseline latencies observed might 
possibly reflect an anxious reaction to novelty. Indeed, it 
has been previously shown that longer-lasting hormonal 
stress responses induce increases in the reactions of the 
animals (i.e., movement activity, freezing, grooming) in a 
new environment (14). Also, activation of the hypothalamus-
hypophysis-adrenal (HHA) axis seems to follow both reac-
tions to novelty and to potential threat stimuli. 
Imipramine efficiently counteracted the effects observed 
with CORT on ETM avoidance. It is interesting to point out 
that long-term administration of monoamine reuptake inhibi-
tors has been found to affect neuronal plasticity in structures 
that modulate defense-related responses, such as the 
hippocampus (which presents high levels of glucocorticoid 
receptors), and to alter brain-derived neurotrophic factor 
levels (for a review, see Ref. 15). In fact, it was previously 
hypothesized that this could contribute to the therapeutic 
effects of these drugs (15). Further investigations are now 
being performed to determine if indeed imipramine alters 
neuronal plasticity induced by chronic CORT.
Nevertheless, imipramine by itself did not show any 
anxiolytic effects. These results are contrary to previous 
observations (10) obtained with the same dose range of 
the drug. However, and corroborating earlier evidence 
(10), imipramine also altered the number of crossings and 
rearings in the open field, thus showing a sedative action. 
Hence, it is possible that in the present case this decrease 
in motor activity masked the anxiolytic effects of the drug. 
On the other hand, it is important to point out that a study 
by our group (11) performed with two other reuptake inhibi-
tors (clomipramine and fluoxetine) failed to show significant 
effects on ETM avoidance, although the drugs efficiently 
inhibited escape latencies, without altering locomotor activ-
ity. These results suggest that the escape measurement is 
more sensitive to treatment with antidepressant agents. The 
reason for this deserves to be better investigated. 
Unlike avoidance measurements, the escape task was 
not significantly altered by treatment with chronic CORT. 
Escape is a defensive reaction performed in response to a 
proximal threat, in this case, direct exposure to an uncon-
ditioned aversive stimulus, i.e., open space. As previously 
mentioned, a study using the same dose of CORT and 
the same procedure adopted in the present investigation 
(implant of 200 mg 21-day release pellets), has shown that 
chronic CORT does not alter defensive behavior induced 
by another type of innate fear stimulus, i.e, exposure to a 
predator odor (4). As with ETM escape, in this particular 
study (4), animals were also placed in direct contact with 
the aversive stimulus (a chamber containing different con-
Figure 2. Effects of chronic corticosterone (200 mg, 21-day release pellets) and 
imipramine (15 mg/kg) on the total number of crossings and rearings in an open 
field. Data are reported as means ± SEM. Measurements were made imme-
diately after the tests in the elevated T-maze. For additional information, see 
legend to Figure 1.
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centrations of trimethylthiazoline, a synthetic odor originally 
derived from fox feces).
In terms of psychopathology, ETM escape has been 
associated with panic disorder (8). Clinical observation has 
shown that although high plasma levels of cortisol accom-
pany anticipatory anxiety and generalized anxiety disorder 
(16), no changes in the HHA axis or in cortisol levels are 
associated with panic attacks or panic disorder (16,17). In 
a similar way, panicogenic stimuli (e.g., caffeine, sodium, 
lactate, CO2) can trigger panic attacks without a concomitant 
increase in cortisol release (for a review, see Ref. 16). On 
the basis of these observations, it has been proposed (16) 
that, in addition to the differences in symptomatology and 
pharmacological response, generalized anxiety and panic 
disorder may affect stress hormones differently. While 
anticipatory anxiety and generalized anxiety disorder acti-
vate both the HHA and the sympathoadrenal axes, a panic 
attack would be an emergency reaction that causes major 
sympathetic activation, but has little effect on the HHA axis. 
Our results seem to corroborate this proposition.
Similar to what has been previously observed (10), 
treatment with imipramine inhibited escape responses, a 
panicolytic-like effect. On the other hand, chronic CORT 
was able to counteract the effects of imipramine. Since 
high levels of this adrenocorticotropic hormone have been 
associated with other clinical conditions (generalized 
anxiety, melancholic depression) but not with panic, these 
data appear to suggest that comorbidity interferes with the 
antipanic effect of the drug. In fact, comorbidity is frequently 
associated with poor compliance and poor response to 
antipanic agents (18). 
Although our results show that chronic CORT does 
not alter ETM escape, a recent study (19) performed with 
another animal model of panic disorder, i.e., electrical 
stimulation of the dorsolateral periaqueductal grey, has dem-
onstrated that the levels of plasma CORT were significantly 
increased after the induction of escape, a result that was 
altered by treatment with the selective serotonin reuptake 
inhibitor escitalopram. Nevertheless, since blood samples 
were collected only 30 min after the escape reaction, it is 
possible that the increases in CORT levels were due to the 
blood sampling procedure adopted (tail clipping), and not 
a response to the activation of the panic circuit. Although 
it is a simple non-surgical blood collecting technique, tail 
clipping involves handling and restraining and may be a 
painful procedure. Animals that experienced a previous 
panic-like reaction are probably more susceptible to showing 
anticipatory anxiety in response to this aversive manipula-
tion. Although the authors raise this concern, they do not 
further discuss it. To investigate this possibility, it would be 
important to use other blood sampling techniques, such 
as decapitation or indwelling catheters. Also, the fact that 
escitalopram decreased CORT levels is not a surprise. 
Like imipramine, escitalopram is not exclusively used for 
the treatment of panic, but also for generalized anxiety and 
depression. Indeed, it has been demonstrated that chronic 
treatment with these drugs decreases CORT levels and 
HHA axis activity (20). 
In conclusion, the present results suggest that chronic 
treatment with CORT facilitates a behavioral defensive 
response that in clinical terms has been associated with 
generalized anxiety disorder. Chronic treatment with imip-
ramine blocks this anxiogenic effect. These results confirm 
previous observations showing that the two responses 
measured by the ETM are in fact associated with distinct 
anxiety disorders (8,10,11) and corroborate clinical data 
(16,17) suggesting that generalized anxiety and panic dis-
order activate different neurobiological substrates, including 
stress hormones.
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